IBDEI16G ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19105,0)
 ;;=L40.9^^64^849^17
 ;;^UTILITY(U,$J,358.3,19105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19105,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,19105,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,19105,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,19106,0)
 ;;=L40.3^^64^849^19
 ;;^UTILITY(U,$J,358.3,19106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19106,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,19106,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,19106,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,19107,0)
 ;;=R21.^^64^849^20
 ;;^UTILITY(U,$J,358.3,19107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19107,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,19107,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,19107,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,19108,0)
 ;;=L25.9^^64^849^6
 ;;^UTILITY(U,$J,358.3,19108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19108,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19108,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,19108,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,19109,0)
 ;;=M34.89^^64^850^31
 ;;^UTILITY(U,$J,358.3,19109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19109,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,19109,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,19109,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,19110,0)
 ;;=M34.0^^64^850^25
 ;;^UTILITY(U,$J,358.3,19110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19110,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,19110,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,19110,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,19111,0)
 ;;=F03.90^^64^850^15
 ;;^UTILITY(U,$J,358.3,19111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19111,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,19111,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,19111,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,19112,0)
 ;;=F06.8^^64^850^22
 ;;^UTILITY(U,$J,358.3,19112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19112,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,19112,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,19112,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,19113,0)
 ;;=F06.1^^64^850^1
 ;;^UTILITY(U,$J,358.3,19113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19113,1,3,0)
 ;;=3^Catatonic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,19113,1,4,0)
 ;;=4^F06.1
 ;;^UTILITY(U,$J,358.3,19113,2)
 ;;=^5003054
 ;;^UTILITY(U,$J,358.3,19114,0)
 ;;=G35.^^64^850^23
 ;;^UTILITY(U,$J,358.3,19114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19114,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,19114,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,19114,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,19115,0)
 ;;=G60.9^^64^850^20
 ;;^UTILITY(U,$J,358.3,19115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19115,1,3,0)
 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,19115,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,19115,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,19116,0)
 ;;=G62.9^^64^850^24
 ;;^UTILITY(U,$J,358.3,19116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19116,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,19116,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,19116,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,19117,0)
 ;;=I63.9^^64^850^14
 ;;^UTILITY(U,$J,358.3,19117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19117,1,3,0)
 ;;=3^Cerebral Infarction,Unspec
